Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Sarepta Therapeutics (SRPT)

53.04 -1.22 (-2.25%)

12-12 16:00

Open:

54.97

Pre. Close:

54.26

High:

55.05

Low:

52.41

Volume:

1,759,644

Market Cap:

3428M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

56.31 - 57.56

57.56 - 58.52

Low:

49.99 - 51.08

51.08 - 51.91

Close:

51.51 - 53.55

53.55 - 55.12

Technical analysis  (as of: 2017-12-12 4:54:34 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 64.09     One year: 67.24

Support:

Support1: 50.51    Support2: 42.02

Resistance:

Resistance1: 54.87    Resistance2: 57.57

Pivot:

54.60

Moving Averages:

MA(5): 53.57     MA(20): 54.78

MA(100): 46.96     MA(250): 37.94

MACD:

MACD(12,26): 0.32     Signal(12,26,9): 0.73

%K %D:

%K(14,3): 43.38     %D(3): 42.73

RSI:

RSI(14): 47.36

52-Week:

High: 57.57  Low: 26.26  Change(%): 76.9

Average Vol(K):

3-Month: 191599  10-Days 156540

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
SRPT has closed above bottom band by 20.0%. Bollinger Bands are 35% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 12 Dec 2017 12:27:18 GMT
How to Trade these Stock After an unavoidable Selloff: Sarepta Therapeutics ...

Thu, 16 Nov 2017 20:03:45 GMT
Atika Capital Management LLC Buys Sarepta Therapeutics Inc, Intuitive Surgical ...

Tue, 12 Dec 2017 16:52:30 GMT
Cheap or Expensive Right Now? – Sarepta Therapeutics, Inc. (SRPT), General ...

Mon, 04 Dec 2017 23:02:39 GMT
Sarepta Therapeutics investors seek revival of fraud lawsuit

Wed, 06 Dec 2017 14:48:45 GMT
The Zacks Analyst Blog Highlights: Sangamo Therapeutics, Sarepta Therapeutics ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

64.63

Shares Float (M)

60.57

% Held by Insiders

6.23

% Held by Institutions

85.59

Shares Short (K)

10600

Shares Short Prior Month (K)

8790

Stock Financials

EPS

-2.040

EPS Est. Current Year

-1.130

EPS Est. Next Year

-0.990

EPS Est. Next Quarter

-0.380

Forward EPS

-0.600

Book Value (p.s.)

10.800

PEG Ratio

367.95

Profit Margin

-112.08

Operating Margin

-194.41

Return on Assets (ttm)

-19.4

Return on Equity (ttm)

-20.8

Qtrly Rev. Growth

Gross Profit (p.s.)

0.082

Sales Per Share

EBITDA (p.s.)

-2.984

Qtrly Earnings Growth

Operating Cash Flow (M)

-282.17

Levered Free Cash Flow (M)

-50.56

atoplab.com

Valuation

P/E

-26.00

P/E Growth Ratio

-0.02

P/BV

4.91

P/S

1883502848.00

P/CF

-12.15

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-07-12

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.